Literature DB >> 16098441

Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction.

Wangde Dai1, Loren E Wold, Joan S Dow, Robert A Kloner.   

Abstract

OBJECTIVES: We determined whether collagen implantation could thicken the infarcted left ventricular (LV) wall and improve LV function.
BACKGROUND: We hypothesized that thickening the infarcted wall by using collagen might result in some benefits that are similar to what previously had been reported when the infarcted wall was thickened with cells.
METHODS: Fischer rats with one-week-old myocardial infarcts were injected with collagen or saline (100 microl) into the scar (n = 12 each group). Six weeks later, LV angiograms, hemodynamics, and regional myocardial blood flow were assessed. The hearts were processed for measurements of postmortem LV volume and histology.
RESULTS: Collagen injection significantly increased scar thickness (719 +/- 26 microm) compared with the saline-treated group (440 +/- 34 microm, p = 2.6 x 10(-6)). By LV angiography, stroke volume was significantly larger in the collagen-treated group (163 +/- 8 microl) than in the saline-treated group (129 +/- 6 microl, p = 0.005), and LV ejection fraction was also greater in the collagen-treated group (48.4 +/- 1.8%) than in the saline-treated group (40.7 +/- 1.0%, p = 0.002). Analysis of regional wall motion demonstrated paradoxical systolic bulging in 5 of 10 saline-treated rats that averaged 20.3 +/- 2.6% of the LV diastolic circumference, but in none of the 11 collagen-treated rats (p = 0.012). The LV end-diastolic and end-systolic volumes were 319 +/- 12 microl and 190 +/- 7 microl in the saline-treated group, respectively. There was a trend for larger LV end-diastolic volumes (343 +/- 23 microl), but smaller end-systolic volumes (180 +/- 16 microl) in the collagen-treated group.
CONCLUSIONS: This study shows that collagen injection thickens an infarct scar and improves LV stroke volume and ejection fraction, and prevents paradoxical systolic bulging after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098441     DOI: 10.1016/j.jacc.2005.04.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  83 in total

1.  Anisotropic reinforcement of acute anteroapical infarcts improves pump function.

Authors:  Gregory M Fomovsky; Samantha A Clark; Katherine M Parker; Gorav Ailawadi; Jeffrey W Holmes
Journal:  Circ Heart Fail       Date:  2012-06-04       Impact factor: 8.790

2.  Synthetic matrices to serve as niches for muscle cell transplantation.

Authors:  Sarah Fernandes; Shannon Kuklok; Joe McGonigle; Hans Reinecke; Charles E Murry
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

3.  Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model.

Authors:  Jamie L Ifkovits; Elena Tous; Masahito Minakawa; Masato Morita; J Daniel Robb; Kevin J Koomalsingh; Joseph H Gorman; Robert C Gorman; Jason A Burdick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

4.  Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure.

Authors:  Hani N Sabbah; Mengjun Wang; Ramesh C Gupta; Sharad Rastogi; Itamar Ilsar; Michael S Sabbah; Smita Kohli; Sam Helgerson; Randall J Lee
Journal:  JACC Heart Fail       Date:  2013-06       Impact factor: 12.035

5.  Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium.

Authors:  Jessica C Garbern; Elina Minami; Patrick S Stayton; Charles E Murry
Journal:  Biomaterials       Date:  2010-12-24       Impact factor: 12.479

6.  Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction.

Authors:  Thomas P Kraehenbuehl; Lino S Ferreira; Alison M Hayward; Matthias Nahrendorf; André J van der Vlies; Eliza Vasile; Ralph Weissleder; Robert Langer; Jeffrey A Hubbell
Journal:  Biomaterials       Date:  2010-10-28       Impact factor: 12.479

7.  Biomimetic matrices for myocardial stabilization and stem cell transplantation.

Authors:  Samuel T Wall; Che-Chung Yeh; Richard Y K Tu; Michael J Mann; Kevin E Healy
Journal:  J Biomed Mater Res A       Date:  2010-09-28       Impact factor: 4.396

8.  Theoretic impact of infarct compliance on left ventricular function.

Authors:  James J Pilla; Joseph H Gorman; Robert C Gorman
Journal:  Ann Thorac Surg       Date:  2009-03       Impact factor: 4.330

9.  Oxime cross-linked injectable hydrogels for catheter delivery.

Authors:  Gregory N Grover; Rebecca L Braden; Karen L Christman
Journal:  Adv Mater       Date:  2013-03-12       Impact factor: 30.849

10.  Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering.

Authors:  Jennifer M Singelyn; Jessica A DeQuach; Sonya B Seif-Naraghi; Robert B Littlefield; Pamela J Schup-Magoffin; Karen L Christman
Journal:  Biomaterials       Date:  2009-07-15       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.